Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity

Endocrinology

Volumn 137, Issue 10, 1996, Pages 4100-4107

  Costantino, Angela ^a   Vinci, Carmela ^a   Mineo, Rossana ^a   Frasca, Francesco ^a   Pandini, Giuseppe ^a   Milazzo, Giovanni ^a   Vigneri, Riccardo ^a   Belfiore, Antonino ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; PROTEIN TYROSINE KINASE; SOMATOMEDIN C;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; AUTOPHOSPHORYLATION; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MITOGENICITY; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0029779883     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.10.8828463     Document Type: Article

References (42)

1. Adelman NE, Hammond ME, Cohen S, Dvorak HF 1979 Lymphokines as inflammatory mediators. In: Pick E, Cohen S, Oppenheim JJ (eds) Biology of the Lymphokines. Academic Press, New York, pp 13-58
2. Mizel SB 1989 The interleukins. FASEB J 3:2379-2388
3. Platanias LC, Vogelzang NJ 1990 Interleukin-1: biology, pathophysiology and clinical prospects. Am J Med 89:621-629
4. Dower SK, Kronheim SR, March CJ, Conlon PJ, Hopp TP, Gillis S, Urdal DL 1985 Detection and characterization of high affinity plasma membrane receptors for human interleukin-1. J Exp Med 162:501-515
5. Onozaki K, Matsushima K, Aggarwall BB, Oppenheim JJ 1985 Interleukin-1 as cytocidal factor for several tumor cell lines. J Immunol 135:3962-3968
6. Lachman LB, Dinarello CA, Llansa ND, Filder IJ 1986 Natural and recombinant human interleukin-1β cytotoxic for human melanoma cells. J Immunol 136:3098-3102
7. Farrar WL, Mizel SB, Farrar JJ 1980 Participation of lymphocyte activating factor (interleukin-1) in the induction of cytotoxin T cell responses. J Immunol 124:1371-1377
8. Gaffney EV, Tsai SC 1986 Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin-1. Cancer Res 46:3834-3837
9. Johnson CS 1993 Interleukin-1: therapeutic potential for solid tumors. Cancer Invest 11:600-608
10. Paciotti FG, Tamarkin L 1988 Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol Endocrinol 2:459-464
11. Danforth DN, Sgagias MK 1993 Interleukin-1 and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res 53:1538-1545
12. Sgagias MK, Kasid A, Danforth DNJ 1991 Interleukin-1β and tumor necrosis factor-α (TNFα) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cells. Mol Endocrinol 5:1740-1747
13. Danforth DN, Sgagias MK 1991 Interleukin-1β blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro. Cancer Res 5:1488-1493
14. Milazzo G, Giorgino F, Damante G, Stampfer MF, Vigneri R, Goldfine ID, Belfiore A 1992 Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52:3924-3930
15. Pezzino V, Milazzo G, Frittitta L, Vigneri R, Erak O, Kasahara M, Le Bon TR, Goldfine ID, Yamaguchi YF 1991 Radioimmunoassay for human insulin-like growth factor-1 receptor: applicability to breast carcinoma specimens and cell lines. Metabolism 40:861-865
16. Osborne CK, Bolan G, Monaco ME, Lippman ME 1976 Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc Natl Acad Sci USA 73:4536-4540
17. Osborne CK, Clemmons DR, Artega CL 1990 Regulation of breast cancer growth by insulin-like growth factors. J Steroid Biochem Mol Biol 37:805-809
18. Costantino A, Milazzo G, Giorgino F, Russo P, Goldfine ID, Vigneri R, Belfiore A 1993 Insulin-resistant MDA-MB 231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Mol Endocrinol 7:1667-1676
19. Whittaker J, Okamoto AK, Thys J, Bell GL, Steiner DF, Hofmann CA 1987 High-level expression of human insulin receptor cDNA in mouse NIH3T3 cells. Proc Natl Acad Sci USA 84:5237-5241
20. Giorgino F, Belfiore A, Milazzo G, Costantino A, Maddux B, Whittaker J, Goldfine ID, Vigneri R 1991 Overexpression of insulin receptors in fibroblast and ovary cells induced a ligand-mediated transformed phenotype. Mol Endocrinol 5:425-459
21. Labarca C, Paigen K 1980 A simple, rapid and sensitive DNA assay procedure. Anal Biochem 72:248-254
22. Pezzino V, Papa V, Trischitta V, Brunetti A, Goodman PA, Treutelaar MK, Williams JA, Maddux BA, Vigneri R, Goldfine ID 1989 Human insulin receptor radioimmunoassay: applicability to insulin-resistant states. Am J Physiol 257:E451-E457
23. + RNA from cells in monolayer. Endocrinology 127:2038-2040
24. Masiakoski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P 1982 Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Res 10:7895-7903
25. Fukui S, Yoshida H, Yamashina I 1981 Sulfohydrolytic degradation of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) and adenosine 5′-phosphosulfate (APS) by enzymes of a nucleotide pyrophosphatase nature. J Biochem 90:1537-1540
26. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID 1995 Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373:448-451
27. Paciotti G, Tamarkin T 1991 Interleukin 1β differentially synchronizes estrogen dependent human breast cancer cells in G1 phase of the cell cycle. Anticancer Res 51:1488-1493
28. Ullrich AJ, Bell RE, Chen Y, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J 1985 Human insulin receptor and its relationship to tyrosine kinase family of oncogenes. Nature 313:756-761
29. Cleatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
30. Levy JR, Hug V 1992 Regulation of insulin receptor gene expression. J Biol Chem 267:25289-25295
31. Reed BC, Kaufman SH, Mackall JC, Student AK, Lane MD 1977 Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 71:4876-4880
32. Vigneri R, Maddux B, Goldfine ID 1984 The effect of phenformin and other adenosine triphosphate (ATP)-lowering agents on insulin binding to IM-9 human cultured lymphocytes. J Cell Biochem 24:177-186
33. Giorgino F, Almahfouz A, Goodyear LJ, Smith R 1993 Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 91:2020-2030
34. Saad MJA, Folli F, Araki E, Hashimoto N, Csermely P, Kahn CR 1994 Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidyl-inositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin and dexamethasone. Mol Endocrinol 8:545-557
35. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID, Vigneri R 1990 Elevated insulin receptor content in human breast cancer. J Clin Invest 86:1503-1510
36. Papa, V, Gliozzo BM, Clark GM, McGuire WL, Moore D, Yamaguchi YF, Vigneri R, Golfine ID, Pezzino V 1993 Insulin-like growth factor-1 receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53:3736-3740
37. Kaleko M, Rutter WJ, Miller AD 1990 Overexpression of the human insulin-like growth factor 1 receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10:464-473
38. Dreyer K 1992 The bioactivity of insulin analog from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8:259-286
39. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N 1989 Analysis of insulin-like growth factor 1 gene expression in malignancy: evidence for paracrine role in human breast cancer. Mol Endocrinol 3:509-517
40. Stewart AJ, Johnson MD, May FEB, Westley BR 1990 Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178
41. Mitchell MS 1988 Combining chemotherapy with biological response modifiers in treatment of cancer. J Natl Cancer Inst 80:1445-1450
42. Usui N, Mimnaugh EG, Sinha B 1991 A role for the interleukin-1 receptor in the synergistic antitumor effects of human interleukin-1α and etoposide against human melanoma cells. Cancer Res 51:769-774